Anne M Filppula

About Anne M Filppula

Anne M Filppula, With an exceptional h-index of 16 and a recent h-index of 14 (since 2020), a distinguished researcher at Helsingin yliopisto, specializes in the field of Drug-drug interactions, drug metabolism, drug transport, PBPK modeling, ADME.

His recent articles reflect a diverse array of research interests and contributions to the field:

Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes–detailed studies on CYP3A inhibitors

Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity

Ticagrelor increases exposure to the breast cancer resistance protein substrate rosuvastatin

Ion‐Specific Hydrogel Microcarriers with Biomimetic Niches for Bioartifical Liver System

Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants

Fabricating biomimetic materials with ice‐templating for biomedical applications

Elucidating the drug-drug interaction risks caused by time-dependent inhibition of CYP3A by hydroxychloroquine metabolites

Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?

Anne M Filppula Information

University

Position

Department of Clinical Pharmacology

Citations(all)

1152

Citations(since 2020)

732

Cited By

713

hIndex(all)

16

hIndex(since 2020)

14

i10Index(all)

18

i10Index(since 2020)

17

Email

University Profile Page

Google Scholar

Anne M Filppula Skills & Research Interests

Drug-drug interactions

drug metabolism

drug transport

PBPK modeling

ADME

Top articles of Anne M Filppula

Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes–detailed studies on CYP3A inhibitors

European Journal of Pharmaceutical Sciences

2024/2/27

Anne M Filppula
Anne M Filppula

H-Index: 11

Mikko Niemi
Mikko Niemi

H-Index: 5

Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity

Human Genomics

2024/2/1

Anne M Filppula
Anne M Filppula

H-Index: 11

Mikko Niemi
Mikko Niemi

H-Index: 5

Ticagrelor increases exposure to the breast cancer resistance protein substrate rosuvastatin

Clinical Pharmacology & Therapeutics

2024/1

Anne M Filppula
Anne M Filppula

H-Index: 11

Mikko Niemi
Mikko Niemi

H-Index: 5

Ion‐Specific Hydrogel Microcarriers with Biomimetic Niches for Bioartifical Liver System

Advanced Functional Materials

2024/4/5

Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants

Pharmacogenetics and Genomics

2023/9/1

Anne M Filppula
Anne M Filppula

H-Index: 11

Mikko Niemi
Mikko Niemi

H-Index: 5

Fabricating biomimetic materials with ice‐templating for biomedical applications

2023/8

Elucidating the drug-drug interaction risks caused by time-dependent inhibition of CYP3A by hydroxychloroquine metabolites

2023/7/2

Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?

2023/7

Elucidating the drug-drug interaction potential of hydroxychloroquine metabolites due to direct and time-dependent inhibition of CYP3A

2023/6/14

Carvedilol is a time-dependent inhibitor of CYP3A

2023/6/14

Elucidating the drug–drug interaction potential of hydroxychloroquine metabolites due to direct and time-dependent inhibition of CYP3A In: ABSTRACTS FROM SECOND NORDIC …

Basic & Clinical Pharmacology & Toxicology

2023/6/1

Advances in the delivery systems for oral antibiotics

2023/6/1

Hydroxychloroquine is metabolized by cytochrome P450 2D6, 3A4, and 2C8, and inhibits cytochrome P450 2D6, while its metabolites also inhibit cytochrome P450 3A in vitro

Drug Metabolism and Disposition

2023/3/1

Mikko Niemi
Mikko Niemi

H-Index: 5

Anne M Filppula
Anne M Filppula

H-Index: 11

Lisääkö tikagrelorin käyttö rosuvastatiinin lihashaittariskiä?

Duodecim

2023

Hydroxychloroquine is metabolized by CYP2D6, CYP3A4, and CYP2C8, and inhibits CYP2D6, while its metabolites also inhibit CYP3A in vitro

Drug Metabolism and Disposition

2023/1/1

Mikko Niemi
Mikko Niemi

H-Index: 5

Anne M Filppula
Anne M Filppula

H-Index: 11

Translational aspects of cytochrome P450‐mediated drug–drug interactions: A case study with clopidogrel

2022/1

Anne M Filppula
Anne M Filppula

H-Index: 11

Comparative hepatic and intestinal efflux transport of statins

Drug Metabolism and Disposition

2021/9/1

Comparative hepatic and intestinal metabolism and pharmacodynamics of statins

Drug Metabolism and Disposition

2021/8/1

An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes–application to establishing CYP2C8 inhibitor …

European Journal of Pharmaceutical Sciences

2021/7/1

Anne M Filppula
Anne M Filppula

H-Index: 11

Mikko Niemi
Mikko Niemi

H-Index: 5

A3-A High-throughput double cocktail approach for evaluating time-dependent inhibition of nine major human cytochrome P450 enzymes

Drug Metabolism and Pharmacokinetics

2020

Anne M Filppula
Anne M Filppula

H-Index: 11

See List of Professors in Anne M Filppula University(Helsingin yliopisto)